Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Journal article

Newton PN. et al, (2020), The Lancet Global Health, 8, e754 - e755

Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data

Journal article

Devine A. et al, (2019), Bulletin of the World Health Organization, 97, 828 - 836

Chloroquine–Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial

Journal article

Awab GR. et al, (2017), The American Journal of Tropical Medicine and Hygiene, 97, 1782 - 1787

A Worldwide Map ofPlasmodium falciparumK13-Propeller Polymorphisms

Journal article

Ménard D. et al, (2016), New England Journal of Medicine, 374, 2453 - 2464

A Population Survey of the Glucose-6-Phosphate Dehydrogenase (G6PD) 563C>T (Mediterranean) Mutation in Afghanistan

Journal article

Jamornthanyawat N. et al, (2014), PLoS ONE, 9, e88605 - e88605